For research use only. We do not sell to patients.
| Name | Taprenepag(CP-544326) |
|---|---|
| Iupac Chemical Name | 2-(3-((N-(4-(1H-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic acid |
| Synonyms | CP-544326; CP544326; CP544326; Taprenepag |
| Molecular Formula | C24H22N4O5S |
| Molecular Weight | 478.523 |
| Smile | N1(N=CC=C1)C1=CC=C(CN(S(=O)(=O)C=2C=NC=CC2)CC=2C=C(OCC(=O)O)C=CC2)C=C1 |
| InChiKey | MFFBXYNKZHTCEY-UHFFFAOYSA-N |
| InChi | InChI=1S/C24H22N4O5S/c29-24(30)18-33-22-5-1-4-20(14-22)17-27(34(31,32)23-6-2-11-25-15-23)16-19-7-9-21(10-8-19)28-13-3-12-26-28/h1-15H,16-18H2,(H,29,30) |
| CAS Number | 752187-80-7 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |